InvestorsHub Logo

Blues44

09/21/21 10:25 AM

#375044 RE: zandant #375040

Here is abit more information on the Phase II trial...https://finance.yahoo.com/news/edesa-biotech-stock-rallying-covid-163742936.html I figured that since the drug in the trial is IV administered it might be of some interest....https://finance.yahoo.com/news/edesa-biotech-announces-positive-phase-120000255.html Here is another article, same comments about how the drug administered is a single dosing, IV delivered medication to critically ill patients. FWIW